{"id":"simvastatin-methylcellulose","safety":{"commonSideEffects":[{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Elevated liver enzymes"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Gastrointestinal disturbance"}]},"_chembl":{"chemblId":"CHEMBL2109198","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Simvastatin is a statin that competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol and triglycerides. Methylcellulose is a cellulose derivative used as a pharmaceutical excipient to enhance drug dissolution, provide sustained release, and improve gastrointestinal tolerability of the active ingredient.","oneSentence":"Simvastatin inhibits HMG-CoA reductase to lower cholesterol, while methylcellulose acts as a solubility enhancer and sustained-release excipient to improve drug bioavailability.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:08:12.907Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia and dyslipidemia"},{"name":"Cardiovascular disease prevention"}]},"trialDetails":[{"nctId":"NCT07194447","phase":"NA","title":"Effect of Locally Applied Simvastatin Gel on Dental Implant Stability and Marginal Bone Level","status":"COMPLETED","sponsor":"Maha Zuhair","startDate":"2024-10-03","conditions":"Dental Implants , Osseointegration , Marginal Bone Loss , Implant Stability","enrollment":42},{"nctId":"NCT03452891","phase":"PHASE4","title":"Effect of Locally-Applied Simvastatin on Clinical Attachment Level and Alveolar Bone in Periodontal Maintenance Patients","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2019-03-01","conditions":"Periodontal Diseases","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Simvastatin"],"phase":"marketed","status":"active","brandName":"Simvastatin-Methylcellulose","genericName":"Simvastatin-Methylcellulose","companyName":"University of Nebraska","companyId":"university-of-nebraska","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Simvastatin inhibits HMG-CoA reductase to lower cholesterol, while methylcellulose acts as a solubility enhancer and sustained-release excipient to improve drug bioavailability. Used for Hypercholesterolemia and dyslipidemia, Cardiovascular disease prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}